SCHEMBL6356763

SCHEMBL6356763

COCCOc1ncc2c(-c3ccccc3)csc2n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 1/20 0.37
PRNP P04156 1/20 0.37
TSHR P16473 2/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
FGFR1 P11362 2/20 0.36
DAPK3 O43293 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
ABL1 P00519 1/20 0.36
NTRK1 P04629 1/20 0.36
LCK P06239 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
MET P08581 1/20 0.36
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
PRKACA P17612 1/20 0.36
FLT1 P17948 1/20 0.36
LTK P29376 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2368984 0.85 FGFR1 (0.41) PRNPTSHRCCNCCDK8FGFR1
SCHEMBL2368787 0.81 CYP1A2 (0.42) SQORTSHRFGFR1DAPK3PRKD3
SCHEMBL2368935 0.76 ALDH1A1 (0.44) TSHRFGFR1DAPK3PRKD3MAP4K4
SCHEMBL30341175 0.74 ALDH1A1 (0.46) TSHRFGFR1DAPK3PRKD3MAP4K4
SCHEMBL6358684 0.73 LMNA (0.40) TSHRFGFR1DAPK3PRKD3MAP4K4
SCHEMBL30341183 0.72 NPC1 (0.47) FGFR1DAPK3PRKD3MAP4K4ABL1
SCHEMBL2368980 0.71 LMNA (0.40) PRNPTSHRCCNCCDK8FGFR1
SCHEMBL14965210 0.71 ADORA1 (0.50) FGFR1DAPK3PRKD3MAP4K4ABL1
SCHEMBL2368300 0.71 ESR1 (0.47) TSHRFGFR1DAPK3PRKD3MAP4K4
SCHEMBL2369195 0.71 DAPK3 (0.40) TSHRFGFR1DAPK3PRKD3MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026935-A1 Compounds XENTION DISCOVERY LTD. 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026935-A1 Compounds KCNJ11, KCNJ1, KCNH1 SQOR 174/4885PRNP 4000/4885TSHR 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.